Sumitomo Dainippon Pharma Co's total assets for Q2 2026 were ¥778.40B, an increase of 6.15% from the previous quarter. DNPUF total liabilities were ¥512.82B for the fiscal quarter, a -7.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.